LexDanaLexDanabeta
Inventor

Michael Wagner

Inventor
Frankfurt am Main, DE

Overview

54→
Patents
1996–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 54 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A61KPreparations for medical, dental or toiletry purposes19%
C07KPeptides12%
C07DHeterocyclic compounds9%
C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients8%
C08LCompositions of macromolecular compounds5%
Y02ATechnologies for adaptation to climate change4%
B29CShaping or joining of plastics2%
C08JWorking-up2%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
PatentTitleYear
11,046,743Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes202110,806,797Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate202010,792,367Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid202010,758,592Exendin-4 derivatives as dual GLP1/glucagon agonists202010,538,567Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists202010,519,211Compounds as peptidic GLP1/glucagon/GIP receptor agonists201910,295,144Molded part, in particular a decorative part and/or cladding part for a vehicle interior, configured as a molded part, and method for producing a molded part201910,253,079Functionalized Exendin-4 derivatives20199,982,029Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists20189,932,381Exendin-4 derivatives as selective glucagon receptor agonists20189,834,527Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals20179,789,165'Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists'20179,775,904'Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists'20179,771,406'Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4'20179,758,561'Dual GLP-1/glucagon receptor agonists derived from exendin-4'20179,750,788'Non-acylated exendin-4 peptide analogues'20179,751,926'Dual GLP-1/GIP receptor agonists'20179,745,360'Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists'20179,694,053'Dual GLP-1/glucagon receptor agonists'20179,688,645'Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa'20179,670,261'Functionalized exendin-4 derivatives'20179,364,807'Component of a biosensor and process for production'20169,365,632'Exendin-4 derivatives as dual GLP1/glucagon agonists'20169,359,489'Polymer composition having a filler content and coextruded sheet obtainable therefrom'20169,309,207'Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa'20169,212,272'Organic colouring agents and coloured polymer compositions with a high stability to weathering'20159,193,848'Flame-resistant, UV-protected polycarbonate moulding compositions of low molecular weight degradation'20159,181,305'Exendin-4 peptide analogues'20159,126,955'Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa'20158,741,992'Polycarbonate compositions with phenolically substituted triazine derivative'20148,722,655'Macrocyclic urea and sulfamide derivatives as inhibitors of tafia'20148,641,784'Organic colouring agents and coloured polymer compositions with a high stability to weathering'20148,628,699'Stabilizer combinations'20148,609,681'Spirocyclic nitriles as protease inhibitors'20138,580,777'Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa'20138,088,925'Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors'20128,044,074'Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them'20118,044,122'Polycarbonate composition containing UV absorber'20118,039,480'Spirocyclic nitriles as protease inhibitors'20118,016,465'Luminous molded part, in particular a decorative part and/or trim part for a vehicle interior'20117,825,264'Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them'20107,754,134'Injection molding process'20107,741,341'Benzimidazole-derivatives as factor Xa inhibitors'20107,465,806'Pyrrole-derivatives as factor Xa inhibitors'20087,358,268'Imidazole derivatives as factor Xa inhibitors'20087,227,721'Multi-directional cartridge memory antenna designs'20077,223,780'Triazole-derivatives as blood clotting enzyme factor Xa inhibitors'20077,144,935'Flame-resistant polycarbonate compositions containing phosphorus-silicon compounds'20066,846,854'Microencapsulated red phosphorus'20056,780,905'Flame-proof polyester molding compositions comprising ZnS'20046,765,047'Microencapsulation of red phosphorus'20046,649,674'Flame-proof polyester molding compositions comprising hydrotalcite, red phosphorus and melamine cyanurate'2003D0438770'Drywall tape mud applicator'20015,519,583'Integrated common mode current decoupler for I/O cables'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1996–2007Based in Longmont, CO, US· patent location history
2003–2006Patents assigned to BAYER AG (5)· patent assignee history
2003–2016Based in Moers, DE· patent location history
2007–2011Based in Alsbach, DE· patent location history
2010–2012Patents assigned to SANOFI AVENTIS (4)· patent assignee history
2010–2021Based in Frankfurt am Main, DE· patent location history
2011–2015Patents assigned to BAYER MATERIALSCIENCE AG (4)· patent assignee history
2012–2016Patents assigned to WAGNER MICHAEL (10)· patent assignee history
2013–2020Patents assigned to SANOFI SA (26)· patent assignee history
2018Based in Kriftel, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANOFI SA262013–2020
WAGNER MICHAELself102012–2016
BAYER AG52003–2006
BAYER MATERIALSCIENCE AG42011–2015
SANOFI AVENTIS42010–2012
Locations
LocationPatentsSpan
Frankfurt am Main, DE282010–2021
Moers, DE122003–2016
Alsbach, DE52007–2011
Kriftel, DE22018
Longmont, CO, US21996–2007